Abstract

Transcription of viral mRNA in cells infected with influenza viruses involves capturing and cleaving the first 10–20 nucleotides of 5′ capped host mRNAs to be used as primers in viral RNA synthesis. A newly developed inhibitor of the viral endonuclease responsible for this cap-snatching shows therapeutic efficacy for the treatment of influenza. To view this Bench to Bedside, open or download the PDF.

Original languageEnglish
Pages (from-to)1367
Number of pages1
JournalCell
Volume177
Issue number6
DOIs
StatePublished - 30 May 2019

Fingerprint

Dive into the research topics of 'Snatch-and-Grab Inhibitors to Fight the Flu'. Together they form a unique fingerprint.

Cite this